prescription drugs

Lawmakers Go Down To Wire On Health Care

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

The Oregon Legislature ended its session on Sunday after a marathon weekend in which it passed several health care bills, including one that went down to the wire.

By:

Lynne Terry

Lower Drug Prices Are ‘Very Feasible’ In Oregon, Advocate says

This article is for premium subscribers!

If you are a premium subscriber that is not logged in, please login now.

By:

Alex Visser

Drugmakers Blamed for Blocking Generics Have Jacked Up Prices , Cost U.S. Billions

An analysis shows that drug companies that may have worked delay the entrance of cheaper competitors onto the market, which resulted in higher prices and cost taxpayers more money over time.

Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis has found.

By:

Sydney Lupkin Kaiser Health News

Bipartisan Support for Drug Price Transparency Shows Limits of PhRMA’s Clout

While transparency advocates did not get everything they wanted from health insurers and pharmacy benefit managers, the drug manufacturers will have to explain steep price hikes beginning July 2019.

Sweeping bipartisan majorities last week passed into law House Bill 4005,setting up a system for the state to demand more transparency from

By:

Chris Gray

Pressure Builds To Cut Medicare Patients In On Prescription Deals

Medicare enrollees, who have watched their out-of-pocket spending on prescription drugs climb in recent years, might be in for a break.

By:

Sarah Jane Tribble; Kaiser Health News

Out-Of-Pocket Costs Often Keep Pricey New Cholesterol Drugs Out Of Reach, Study Finds

Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients’ out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.

By:

Michelle Andrews; Kaiser Health News

Facebook Live: The Prescription Drug Pricing Pipeline

Who contributes to what you pay at the pharmacy? Why are prescription drugs so expensive in the United States?

By:

Kaiser Health News

Whichever Way ‘Repeal and Replace’ Blows, Pharma Is Due For Windfall

The pharmaceutical industry could see windfall profits from a little-noticed tweak to the insurance market tucked into the Trump administration’s draft executive order on drug prices, experts say.

By:

Emily Kopp; Kaiser Health News

Amount Of Opioids Prescribed In U.S. Has Been Falling Since 2010

Ryan Hampton was sitting at his computer at work when he began sweating, feeling sick and unable to concentrate. He went to the bathroom, splashed water on his face and called his friend for help.

That was the day he realized he was addicted to opioids.

By:

Vickie Connor; Kaiser Health News

Sky-High Prices For Orphan Drugs Slam American Families And Insurers

Before Luke Whitbeck began taking a $300,000-a-year drug, the 2-year-old’s health was inexplicably failing.

A pale boy with enormous eyes, Luke frequently ran high fevers, tired easily and was skinny all over, except his belly stuck out like a bowling ball.

By:

Sarah Jane Tribble and Sydney Lupkin; Kaiser Health News

The Lund Report

Oregon's most vital source of health news